Global Leader in Cancer Clinical Trials
2025 ASCO® Annual Meeting
May 30 – June 3, 2025
Leaders from across the SCRI network are highlighting the latest advances in research through more than 155 accepted abstracts and presentations at the 2025 American Society of Clinical Oncology (ASCO®) Annual Meeting, taking place in Chicago from Friday, May 30 – Tuesday, June 3. Learn more about SCRI and our presence at this year’s ASCO.
The Science of Collaboration Begins with Us
We partner with pharmaceutical and biotech companies, physicians and patients to advance the science of cancer treatments.
Sarah Cannon Research Institute (SCRI) is a global leader in oncology research, conducting clinical trials in the community for more than 30 years. Our contributions to pivotal research have helped to advance the majority of new cancer therapies approved by the FDA today.
200+
locations in 20 states
1 in 5
patients with cancer reached through our affiliated sites
1,300+
research physicians
